According to a new unpublished study, a compound used to treat genetic deficits may be effective against symptoms linked to autism.
Scientists announced at the 2014 Society for Neuroscience Annual Meeting that experimental treatments using an immunosuppressant called rapamycin have been met with success when used on adolescent mice. At 6 weeks old, the rodents are at a similar development phase to that of a human teenager.
This treatment has previously been used to treat a genetic mutation associated with the TSC1 gene. Abnormalities in this gene can cause a condition called tuberous sclerosis, which is characterized by the growth of benign tumors. About half of the population that suffers from tuberous sclerosis also has austim spectrum disorder.
It was observed that mice who lacked TSC1 in their Purkinje cells, neurons located in the cerebellum, exhibited autism-like symptoms, such as social difficulties, narrow interests, and repetitive behaviors, when they reach 2 months of age. It was noticed that when these cells died, symptoms associated with autism became apparent.
A previously released study demonstrated that rapamycin could prevent the symptoms when used on mice that were 7 days old. It was however not determined how effective the treatment was in older mice. In the most recent study, researchers found treated at 6 weeks of age did not develop these behaviors.
The results suggest that this therapy may be used to reduce- or even reverse- behaviors associated with autsim in children of a wide age range. Though the therapy is still in the developmental stages, these findings could be indicate promising discoveries in the field of behavioral treatment for children with autism, even at the later stages.
The average age of an autism diagnosis in children is 4 years. Older children who were diagnosed years ago are often still searching for treatment options into their teenage years, since they may not have had access to intervention in the formative years. Since them symptoms are not always understood at the onset, others are not diagnosed until adolescence, and some not until adulthood. Along with traditional speech therapy, occupational therapy, and psychiatric treatment, biological methods of treatment could signal a huge leap in our understanding of autism spectrum disorder.